At Pubrica, we provide end-to-end solutions for biotechnology research, development, and commercialization. Our expert teams help biotech companies navigate regulatory landscapes, optimize clinical strategies, and accelerate innovation with precision and compliance.
The biotechnology industry is at the forefront of scientific innovation, combining biology, technology, and data science to develop groundbreaking solutions for healthcare, agriculture, industrial processes, and environmental sustainability. From genomics and molecular diagnostics to regenerative medicine and biopharmaceuticals, biopharmaceuticals drives the development of therapies, vaccines, and technologies that improve lives globally.
With rapid scientific advancements, stringent regulatory requirements, and complex clinical pipelines, biotechnology organizations require expert guidance to navigate research, regulatory compliance, and commercialization. Pubrica specializes in supporting biotechnology companies across all stages of development, ensuring scientific integrity, regulatory compliance, and operational excellence.
Currently, there are more than 250 biotechnology healthcare products and vaccines available to patients, many of which treat previously untreatable diseases. More than 13.3 million farmers around the world use agricultural biotechnology to increase yields, prevent damage from insects and pests, and reduce farming's impact on the environment.
We provide end-to-end support for biotechnology companies, helping them accelerate research, ensure regulatory compliance, and bring breakthrough products to market efficiently. Our expertise spans multiple domains:
Assistance with genetic engineering, cell therapy, gene editing, and molecular diagnostics, from preclinical studies to clinical translation.
End-to-end clinical trial design, protocol development, and study management tailored to biotech therapeutics.
Strategic guidance for market entry, health economics, and reimbursement planning for biotech products.
Guidance and support in biologics, biosimilars, vaccines, and therapeutic proteins, ensuring compliance with global regulatory standards.
Comprehensive regulatory strategy, submissions, and documentation for biotechnology products across multiple markets.
High-quality scientific writing, manuscript development, and regulatory communication tailored to complex biotech innovations.
Biotechnology is a broad field that applies biological systems, organisms, or derivatives to develop products and technologies for various industries. It can be classified into several types based on applications, techniques, and the focus area. Here's a clear breakdown:
At Pubrica, we provide specialized scientific, regulatory, and publishing support across diverse segments of the biotechnology industry. Our services are tailored to meet the unique needs of each segment, enabling innovation, compliance, and high-quality dissemination of research. Key segments we serve include:
We support companies involved in the development of novel therapeutics, vaccines, and diagnostic tools. Our services encompass clinical trial support, regulatory documentation, and scientific communication to ensure innovative medical solutions reach the market efficiently.
Our expertise extends to plant genetics, crop improvement, and sustainable farming technologies. We assist Agri-biotech firms in research documentation, regulatory compliance, and product development strategies.
We work with organizations leveraging microorganisms, enzymes, and bio-based processes for industrial applications. From biofuels to biodegradable materials, we provide guidance on process optimization, quality standards, and regulatory requirements.
Our team aids companies focused on waste management, bioremediation, and environmental sustainability. We deliver research support, impact assessments, and regulatory documentation to advance eco-friendly biotech solutions.
We cater to biotech firms developing biologics, biosimilars, and advanced therapeutics. Services include scientific writing, regulatory submissions, clinical data analysis, and publication support to accelerate market entry.
We assist companies in developing health-promoting products derived from biological sources. Our services cover research validation, regulatory compliance, and market-ready product documentation.
Our authors share Pubrica’s expert content in top-tier journals, conferences, and platforms, maximizing and amplifying its recognition and reach. Our placement will enhance our visibility and elevate our standing in an authoritative capacity.
Paper Title: Novel technologies and their applications in biotechnology and the life sciences.
Author: Deeni Y, Beccari T, Dundar M
Journal Name: Journal of Biotechnology
Publisher: Elsevier
Impact factor: 3.9
Pubrica’s team of industry specialists offers unrivalled expertise and perspectives to provide complete solutions with precision and originality. Through a mix of both experience and specialization, they strive for excellence in everything they do.
PhD - Biotechnology
PhD - Biotechnology
PhD - Biotechnology
Pubrica’s deep understanding of the biotech sector allowed us to enhance our manuscript quality and compliance with international standards. Their support made a significant difference in our publication success.
— Dr. Jonathan Lee
Director of Research, Genova Biotech
USA
Working with Pubrica has been transformative for our biotech research team. Their expertise in regulatory documentation and scientific communication helped us streamline submissions and accelerate our projects.
— Dr. Meera Sharma
Chief Scientific Officer, BioGenix Labs
India
The team at Pubrica brings exceptional precision and scientific rigor to every project. Their insights into biotechnology trends and regulatory requirements were invaluable to our R&D process.
— Dr. Ananya Rao
Head of R&D, CellTech Innovations
Singapore
Journals expect a clear structure for case reports and review articles, featuring precise objectives, rigorous timeline analysis..
Publishing a case report involves more than clinical knowledge; it also demands strategic journal targeting, matching visibility metrics..
Effective patient education materials (PEMs) are crucial for promoting health literacy, enhancing compliance, and bridging care delivery gaps..